Form 4: Gabelli Healthcare & WellnessRx Trust Director Increases Stake Through Open Market Purchases

Mario J. Gabelli, a director of Gabelli Healthcare & WellnessRx Trust, has increased his holdings through open market purchases of common shares.

Summary

• Mario J. Gabelli, a director and control person of the adviser for Gabelli Healthcare & WellnessRx Trust, has reported purchasing additional shares of the company's common stock.
• On December 12, 2024, Mr. Gabelli acquired 3,456 shares at a price of $10.30 per share.
• On December 13, 2024, he purchased another 544 shares at $10.12 per share.
• Following these transactions, Mr. Gabelli directly owns 225,872 shares.
• He also indirectly owns 312,226 shares through GGCP, Inc., 8,000 shares through Associated Capital Group, Inc., 6,380 shares through GPJ Retirement Partners, and 2,000 shares through a trust account.
• Mr. Gabelli disclaims beneficial ownership of the indirectly held shares beyond his pecuniary interest in those entities.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive due to the director's open market purchases, which typically indicate confidence in the company's future. However, the purchases are not large enough to warrant a very high score.

Positives

• The director's open market purchases signal confidence in the company's prospects.
• Increased insider ownership can be viewed positively by investors.

Industry Context

Insider buying is often seen as a positive indicator in the investment community, suggesting that those with the most knowledge of the company's prospects are optimistic about its future. This activity is particularly relevant in the context of closed-end funds like Gabelli Healthcare & WellnessRx Trust, where management's confidence can influence investor sentiment.

Comparison to Industry Standards

• Comparing this to other closed-end funds, insider buying is a common occurrence, but the scale and frequency can vary significantly.
• For example, similar transactions in funds like BlackRock Health Sciences Trust (BME) or Tekla Healthcare Opportunities Fund (THQ) are closely watched by investors as indicators of management's view on the fund's valuation and future performance.
• The size of Gabelli's purchases, while not exceptionally large, is still a notable signal of confidence.

Stakeholder Impact

• Shareholders may view the director's purchases as a positive sign, potentially increasing investor confidence.
• The purchases could have a minor positive impact on the stock price.

Key Dates

Keywords

Gabelli Healthcare & WellnessRx Trust, GRX, Mario J. Gabelli, insider trading, beneficial ownership, share purchase, director, open market